EUROPE'S LARGEST CELL & GENE THERAPY EVENT

 

2,500+

Attendees

300+

Speakers

100+

Exhibitors

100+

Biotech Start-Ups

2

Days

 

What is the Advanced Therapies Congress?

 

Conference

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development with 10 tracks of content over 2 days.

Exhibition

100 leading solution providers to meet your needs across all stages of cell and gene therapy development
 

SEE PAST EXHIBITORS

Networking

Connect with thousands of cell and gene therapy experts in 12+ hours of built-in 1-2-1 networking
 
 

GET YOUR TICKET 

Our incredible line-up of speakers

 

Kinnari Patel
President & COO
Rocket Pharma
Kinnari Patel speaking at Advanced Therapies Congress
Jordan Schecter
Vice President   | Multiple Myeloma DAS Leader
Johnson & Johnson
Jordan Schecter speaking at Advanced Therapies Congress
Oluwayemisi Corinaldi
Senior Director, Head of EU/International Regulatory Affairs
Spark Therapeutics, Inc.
Oluwayemisi Corinaldi speaking at Advanced Therapies Congress
Nick France
Vice President, Head: Genomic Medicine Development Unit
Alexion, AstraZeneca Rare Disease
Nick France speaking at Advanced Therapies Congress
Francis Pang
Senior Vice President, Global Market Access and Geographic Expansion
Orchard Therapeutics
Francis Pang speaking at Advanced Therapies Congress
Paolo Morgese
VP Public Affairs, Europe
ARM 
Paolo Morgese speaking at Advanced Therapies Congress
Joshi Venugopal
General Manager and Head of Europe
Novartis Gene Therapies
Joshi Venugopal speaking at Advanced Therapies Congress
Katja Berg
Global Director, Innovative Value and Access Strategy, Global Market Access and Pricing, BBU
AstraZeneca
Katja Berg speaking at Advanced Therapies Congress
Olga de la Rosa
Madrid Cell Therapy Technology Head
Takeda
Olga de la Rosa speaking at Advanced Therapies Congress
Raphael G. Ognar
President & CEO, Co-founder
NKILT Therapeutics
Raphael G. Ognar speaking at Advanced Therapies Congress
John Maher
CSO
Leucid Bio
John Maher speaking at Advanced Therapies Congress
Volker Huppert
Chief Operating Officer
Glycostem
Volker Huppert speaking at Advanced Therapies Congress

 

Covering the entire pipeline of ATMPs

 

The Advanced Therapies Congress brings together speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and startup companies, researchers, clinicians, academics, HTAs, payers, regulators.

 

Get your ticket now
From £295 OFFER ENDS 11 DECEMBER   

Content Themes

 
Evidence, Pricing & Access
Ensuring clinical success - Tackling large scale regulatory challenge - Finding the right framework for reimbursement and market access - Cross-border healthcare - Outcome based agreements
Gene Modified Cell Therapy
Autologous vs allogeneic - Tackling solid tumours - Combination therapy - CAR-T, NK, Gamma-Delta cells - Patient stratification and precision medicine approaches
Cell Therapy
Stem cells - Regenerative Medicine - MSCs vs iPSCs - Cord blood advancements
Gene Therapy
Next generation of gene therapy - Moving from rare to more common diseases - Tackling immunogenicity - Rare diseases & orphan drugs - Novel gene delivery systems
Cell Therapy Manufacturing
Automation & closed systems - Scaling up to commercial level - Keeping costs low - In house vs outsourcing
Viral Vector Manufacturing
Continuous manufacturing - Scaling up for commercial production - In house vs outsourcing
Clinical Trials & Development
Ensuring clinical success - Clinical and nursing perspectives - Moving from clinical to commercial
Gene Editing
Latest cutting edge technology - Latest academic research - Safety & ethics
Immunotherapy
Immunotherapy for solid tumours - AI in oncology - Precision medicine
Supply Chain & Logistics
Logistics, transportation, distribution & cold chain - Moving from clinical to commercial - Patient experience - Supply chain - Point of care delivery
Regulation
Tackling large scale regulatory challenges - Patient informed policy decisions
Innovation Showcase
Latest in academic research - Latest cutting-edge technologies success - Tackling large scale regulatory challenges - Finding the right framework for reimbursement and market access - Cross-border healthcare - Outcome based agreements
Start-ups
Company presentations from exciting new start-ups - Investor perspectives
patient delivery
Challenges in clinical adoption, patient pathways and improving accessibility, Initial and ongoing care


"Great people and content; lots of opportunities to dialogue with experts on our sector"

– President & CEO, NKILT Therapeutics

 
"Excellent networking activities with top level actors in the field of advanced therapies"

– Professor, University of Pisa
 
"Great mix of suppliers, manufacturers, Sponsors, exhibitors and presentations"

– Vice President of Operations, Adaptimmune

 

Join us in London | 18-19 March 2025

 

 

 

GET YOUR TICKET NOW


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150